希少疾患にフォーカスを当てた米国発バイオファーマ
既存製品に加え、複数のパイプラインを保持

Summary:
The Associate Director (Assoc Dir), Scientific Communications (Sci Comm) plays a crucial role within the Value Evidence Outcomes (VEO)/Publication & Sci Comm Team in Medical Affairs of Japan. The Asso Dir of Sci Comm is responsible for planning and executing of a comprehensive Japan Sci Comm strategy, ensuring the development of high-quality, accurate, and consistent scientific deliverables that align with the company’s business including strategic imperatives and Strats/Brand Plan, Global Sci Comm strategies and plan, and Japan medical strategies of the company’s portfolio. This involves effectively communicating and disseminating our company’s areas of interest and our generated data. Additionally, this role encompasses involvement in the development of congress strategies to drive cohesive and meaningful communications to diverse audiences. The Asso Dir of Sci Comm collaborates closely with various cross-functional teams within our business, including, but not limited to, the Global Medical Strategy, Publication & Sci Comm Team, each function of Japan MA, Clinical Development, Commercial, and Market Access/Patient Advocacy, as well as external stakeholders. This position reports to the Director, VEO/Publication & Sci Comm in Medical Affairs of Japan and is based at the Tokyo Office.

Roles and Responsibilities:
• Lead the development of Sci Comm plans and scientific deliverables including design of lay summaries, and maintenance of Japanese Lexicon.
• Ensure delivery of high-quality, fair-balanced, scientifically/clinically accurate deliverables for medical communication in accordance with established timelines, compliance guidelines/policies, and budgets.
• Ensure deliverables are in alignment with business strategy/plan, medical affairs strategy/plan and our clinical development programs.
• By maintaining close communication with the Global Sci Comm Team, the following roles are undertaken:
1) Ensure a thorough understanding of global materials and maintain them appropriately. Scrutinizing global materials and applying necessary materials to Japan (e.g. creating translated versions of materials for use in Japan). Introducing Japanese materials usable globally to the Global Sci Comm Team and supporting their utilization globally.
2) Lead the development of congress strategies in Medical Affairs with cross functional teams of Medical Affairs in alignment with Sci Comm plans. 3) Contribute internal trainings including trainer trainings and/or external education (e.g., via MA Webinar) to disseminate our delivered scientific materials accurately.
• Lead the development of the scientific strategy of the Patient Advocacy Team as an interface with J-medical experts and patient associations/groups to identify gaps in the medical community of Japan.
• Manage external vendors, contractors and medical agencies assisting with medical content planning and execution.

• Master’s degree in a scientific discipline and/or equivalent experience in required elements is mandatory. Advanced degree holder is highly preferred (e.g., PhD, PharmD or MD). Experience in pulmonology, bacterial infection, cardiovascular diseases and/or allergy/ immunology is highly preferred and advantageous.
• For a candidate with a degree in medicine: must own a presently active license for the practice of medicine in Japan (foreign license holder will NOT be considered). A board certification in the field of pulmonology, bacterial infection, cardiology and/or allergy/ immunology is highly valued.
• Minimum 10 years’ relevant experience in the pharmaceutical/biotech industry of Global setting in Japan, primarily any of publication, scientific materials/contents creation, external (e.g. HCPs, patients associations) and/or educational communications (e.g. Medical Information, Medical Education), or scientific trainer in Medical/Scientific Affairs is required.
• Minimum 3 years’ experience demonstrated success in design and implementation of Sci Comm Strategies including congress strategies, scientific deliverables development and digital asset generation are highly preferred.
• Minimum 3 years’ experience of medical material review scientifically are preferred.
• Native-level fluency in Japanese and high-level business fluency in English is a must. Excellent written and verbal communication skills, with the ability to understand and effectively communicate complex scientific and clinical data to internal and external stakeholders.
• Expertise in the assessment and the application of scientific/clinical data to strategy with pull through to externally facing deliverables.
• Key attributes for success in this role include active leadership and analytical skills, the ability to work autonomously, and adeptness at managing multiple ongoing workstreams while prioritizing tasks effectively.
• Ability to work effectively within collaborative and cross-functional teams.
• Ability to manage external vendors and provide clear, concise direction.
• Solid understanding of pharmaceutical business, including drug research and development, manufacturing, commercialization, health technology assessment and Market Access.
• Expert knowledge of relevant guidance including, but not limited to International Committee of Medical Journal Editors (ICMJE)/Good Publication Practice 4 (GPP4), Japan Pharmaceutical of Manufacturers Association (JPMA) guide, Guidelines for Provision of Sales Information on Prescription Drugs.

Others
• Must successfully exhibit our five (5) core corporate competencies of Collaboration, Accountability, Passion, Respect and Integrity, along with any other position specific competencies.
• Individuals must demonstrate the ability to interact successfully in a fast-paced, dynamic and culturally diverse workplace.
• Non-smoker (must).
• Up to 15% travel for congresses in Japan and overseas, meetings with external stakeholders and venders, and meetings in our global offices.